Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rafael Cano is active.

Publication


Featured researches published by Rafael Cano.


Histopathology | 2011

Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study

Laia Bernet; Rafael Cano; Marcos Carrasco Martínez; Basilio Dueñas; Xavier Matias-Guiu; Lluisa Morell; José Palacios; Ricardo Rezola; María José Robles-Frías; Irune Ruiz; Ana Velasco; Begoña Vieites; Francisco Sevilla; José Torró; José Medrano; Blai Ballester

Bernet L, Cano R, Martinez M, Dueñas B, Matias‐Guiu X, Morell L, Palacios J, Rezola R, Robles‐Frias M, Ruiz I, Velasco A, Vieites B, Sevilla F, Torro J, Medrano J & Ballester B
(2011) Histopathology 58, 863–869
Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study


Journal of Clinical Gastroenterology | 2010

Prevalence of nonpolypoid colorectal neoplasms in symptomatic patients scheduled for colonoscopy: a study with total colonic chromoscopy.

Marco Bustamante-Balén; Laia Bernet; Rafael Cano; Virginia Pertejo; Julio Ponce

Objectives: (i) To determine the prevalence of nonpolypoid colorectal neoplasms (NP-CRNs) in a prospective cohort of patients of a Mediterranean area; (ii) to compare the characteristics of NP-CRNs with those of polypoid adenomas, focusing on the rate of high-grade dysplasia (HGD) and carcinoma; (iii) to evaluate the characteristics of patients harboring NP-CRNs versus patients with protruding adenomas (P-CRNs). Patients and Methods: A prospective, cross-sectional observational study was made in which consecutive unselected patients were scheduled for colonoscopy and pancolonic chromoendoscopy. The Paris Classification of Superficial Neoplastic Lesions was used to classify the detected lesions, and the revised Vienna criteria were applied to describe the grade of dysplasia. All examinations were performed by the same endoscopist, and all samples were reviewed by the same pathologist. Results: A total of 290 patients were included, and 613 neoplasms were detected—26% of them being NP-CRNs. The prevalence of NP-CRNs was 34.1% [95% confidence interval (CI): 28.8%-39.7%]. The proportion of HGD or carcinoma in NP-CRNs was 2.5% (95% CI: 0.8%-5.9%), versus 2.9% in P-CRNs (95% CI: 1.6%-4.7%). Size larger than 10 mm [odds ratio: 22.7 (95% CI: 5.2-99.2)] and a pedunculated morphology [odds ratio: 5.7 (95% CI: 1.3-24.3)] were related to the presence of HGD or carcinoma. A relationship between increased size and HGD or carcinoma was found for all morphologies. Patients harboring only NP-CRNs and patients harboring only P-CRNs were similar for all the variables collected. Conclusions: NP-CRNs have a high prevalence in our region, but show a proportion of HGD and carcinoma similar to that seen in P-CRNs. No patient variable is predictive of the presence of a NP-CRN.


Gland surgery | 2012

Metastatic sentinel node and axillary lymphadenectomy revisited.

Laia Bernet; Rafael Cano

Complete axillary lymph node dissection (ALND) is an integral part of the surgical treatment for breast carcinoma in spite of carrying a high morbidity and frequent secondary side effects.


Journal of Experimental & Clinical Cancer Research | 2016

Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase

Franco Di Filippo; Simona Di Filippo; Anna Maria Ferrari; Raffaele Antonetti; Alessandro Battaglia; Francesca Becherini; Laia Bernet; Renzo Boldorini; Catherine Bouteille; Simonetta Buglioni; Paolo Burelli; Rafael Cano; Vincenzo Canzonieri; Pierluigi Chiodera; Alfredo Cirilli; Luigi Coppola; Stefano Drago; Luca Di Tommaso; Privato Fenaroli; Roberto Franchini; Andrea Gianatti; Diana Giannarelli; Carmela Giardina; Florence Godey; Massimo Grassi; Giuseppe B. Grassi; Siobhan Laws; Samuele Massarut; Giuseppe Naccarato; Maria Iole Natalicchio

BackgroundTumor-positive sentinel lymph node (SLN) biopsy results in a risk of non sentinel node metastases in micro- and macro-metastases ranging from 20 to 50%, respectively. Therefore, most patients underwent unnecessary axillary lymph node dissections. We have previously developed a mathematical model for predicting patient-specific risk of non sentinel node (NSN) metastases based on 2460 patients. The study reports the results of the validation phase where a total of 1945 patients were enrolled, aimed at identifying a tool that gives the possibility to the surgeon to choose intraoperatively whether to perform or not axillary lymph node dissection (ALND).MethodsThe following parameters were recorded: Clinical: hospital, age, medical record number; Bio pathological: Tumor (T) size stratified in quartiles, grading (G), histologic type, lymphatic/vascular invasion (LVI), ER-PR status, Ki 67, molecular classification (Luminal A, Luminal B, HER-2 Like, Triple negative); Sentinel and non-sentinel node related: Number of NSNs removed, number of positive NSNs, cytokeratin 19 (CK19) mRNA copy number of positive sentinel nodes stratified in quartiles. A total of 1945 patients were included in the database. All patient data were provided by the authors of this paper.ResultsThe discrimination of the model quantified with the area under the receiver operating characteristics (ROC) curve (AUC), was 0.65 and 0.71 in the validation and retrospective phase, respectively. The calibration determines the distance between predicted outcome and actual outcome. The mean difference between predicted/observed was 2.3 and 6.3% in the retrospective and in the validation phase, respectively. The two values are quite similar and as a result we can conclude that the nomogram effectiveness was validated. Moreover, the ROC curve identified in the risk category of 31% of positive NSNs, the best compromise between false negative and positive rates i.e. when ALND is unnecessary (<31%) or recommended (>31%).ConclusionsThe results of the study confirm that OSNA nomogram may help surgeons make an intraoperative decision on whether to perform ALND or not in case of positive sentinel nodes, and the patient to accept this decision based on a reliable estimation on the true percentage of NSN involvement. The use of this nomogram achieves two main gools: 1) the choice of the right treatment during the operation, 2) to avoid for the patient a second surgery procedure.


Ultrastructural Pathology | 2015

Ultrastructural Pathology of Anaplastic and Grade II Ependymomas reveals Distinctive Ciliary Structures – Electron Microscopy Redux

Clara Alfaro-Cervello; Mario Soriano-Navarro; Mónica Ramírez; Laia Bernet; Marcos Martinez Banaclocha; Rafael Cano; Rosa M. Reyes Santías; Jerónimo Forteza-Vila; Jose Manuel Garcia-Verdugo

ABSTRACT Ependymoma tumors likely derive from the ependymal cells lining the CNS ventricular system. In grade II ependymomas, tumor cells resemble typical ependymocytes, while anaplastic ependymomas are poorly differentiated. We studied three grade II and one anaplastic ependymoma, focusing on the ciliary structures. To unambiguously characterize the ultrastructure and number of cilia, we performed electron microscopy serial section analysis of individual cells. Differentiated ependymomas contained large basal bodies and up to three cilia, and lacked centrioles. Anaplastic ependymoma cells showed instead two perpendicularly oriented centrioles and lacked cilia or basal bodies. These findings could contribute to understand the mechanisms of ependymoma aggressiveness.


Revista Española de Patología | 2014

Consenso sobre la biopsia selectiva del ganglio centinela en el cáncer de mama. Revisión 2013 de la Sociedad Española de Senología y Patología Mamaria

Laia Bernet; Antonio Piñero; Sergi Vidal-Sicart; Vicente Peg; Julia Giménez; Manuel Algara; Basilio Dueñas; Francesc Tresserra; Rafael Cano; José Manuel Cordero; Beatriz Navarro; Josep Torró; Ricardo Pardo; David Ramos; Arantxa Moreno Elola; Virginia Vallejos; Carlos Vazquez; Marina Álvarez Benito; José Luis Raya Povedano; Carmen Carreira Gómez; Josefa Galobardes Monge; Edelmiro Iglesias; Carlos Fuster; Ana Lluch; Angel Martinez Agulló


Journal of Experimental & Clinical Cancer Research | 2015

Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method

F. Di Filippo; D. Giannarelli; C. Bouteille; Laia Bernet; Rafael Cano; G. Cunnick; Anna Sapino


The Breast | 2017

Role of total tumour load of sentinel lymph node on survival in early breast cancer patients

Vicente Peg; Irene Sansano; Begoña Vieites; Laia Bernet; Rafael Cano; Alicia Córdoba; Magdalena Sancho; María Dolores Martín; Felip Vilardell; Alicia Cazorla; Martin Espinosa-Bravo; Jose Perez-Garcia; Javier Cortes; Isabel T. Rubio; Santiago Ramón y Cajal


Medicina Clinica | 2004

Enfermedad de Whipple diagnosticada por técnica de reacción en cadena de la polimerasa

Ángel Zúñiga; Laia Bernet; Marcos Bustamante; Rafael Cano


Journal of Clinical Oncology | 2016

Analysis of total tumor load of sentinel lymph node as a prognostic factor in patients with early breast cancer.

Vicente Peg; Irene Sansano; Begoña Vieites; Laia Bernet; Rafael Cano; Alicia Cordoba; Magdalena Sancho; María Martin; Felip Vilardell; Martin Espinosa-Bravo; Jose Manuel Perez-Garcia; Javier Cortes; Isabel T. Rubio; Santiago Ramón y Cajal

Collaboration


Dive into the Rafael Cano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Begoña Vieites

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Isabel T. Rubio

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Espinosa-Bravo

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Santiago Ramón y Cajal

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Ramos

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge